People: Bayer AG (BAYGn.DE)
Prof. Dr. Wolfgang Plischke has been Member of the Supervisory Board of Bayer Aktiengesellschaft since April 30, 2016. He is Member of the Audit Committee and Chairman of the Innovation Committee at the Company. He was Member of the Management Board, responsible for Innovation, Technology and Environment at the Company from March 1, 2006 to 2014. From July 1, 2002 until his appointment to the Bayer AG Board, he was a Member of the Bayer HealthCare Executive Committee and head of the Pharmaceuticals Division. In 1988, he was placed in charge of marketing in the Pharmaceuticals Business Group in Germany and in 1991 he was appointed head of International Strategic Marketing. In 1995, he became President of Bayer Yakuhin Ltd., Japan, with responsibility for Pharmaceuticals and Consumer Care. In 2000, he took over as head of the Pharmaceuticals Business Group in North America. He joined Bayer in 1980. He has been Member of the Board of Walter-Siegenthaler-Gesellschaft fuer Fortschritte in der Inneren Medizin e. V., Member of the Board of Robert-Koch-Stiftung e. V., Honorary Professor of Business Chemistry at Ludwig Maximilian University of Munich, Member of the University Council of the University of Hohenheim, Chairman of the Supervisory Board of Evotec AG and Member of the Senate of Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren e. V. He studied Biology at Universitaet Hohenheim, where in 1979 he obtained doctorate degree.
|Total Annual Compensation, EUR||167,000|
|Restricted Stock Awards, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||--|
|Fiscal Year Total, EUR||167,000|